https://www.etoro.com/it/markets/atra
Scopri prezzi azionari, quotazioni, news e previsioni degli analisti su Atara Biotherapeutics Inc in tempo reale su eToro. Analisi dei trend di mercato e delle...
atara biotherapeuticsle notizieilprezzodelle
https://www.pharmaceutical-technology.com/data-insights/ata-3219-atara-biotherapeutics-net-present-value/
ATA-3219 is a gene-modified cell therapy commercialized by Atara Biotherapeutics, with a leading Phase I program in Diffuse Large B-Cell Lymphoma;Mantle Cell...
net present valuerisk adjustedcurrentvaluation
https://www.pharmaceutical-technology.com/data-insights/atara-biotherapeutics-gets-grant-for-treatment-of-solid-malignant-tumors-using-antigen-specific-t-cells/
Discover how Atara Biotherapeutics Inc's patent revolutionizes cancer treatment with antigen-specific T cells for solid tumors. Learn about managing tumor...
meta titleatara biotherapeuticsincpatenttreatment
https://www.benzinga.com/news/earnings/23/11/35705816/crude-oil-rises-over-1-tapestry-posts-upbeat-earnings
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64...
crude oilrisestapestrypostsupbeat
https://www.insidermonkey.com/blog/should-you-buy-atara-biotherapeutics-inc-atra-392623/
Is Atara Biotherapeutics Inc (NASDAQ:ATRA) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of...
atara biotherapeuticsbuyincatrainsider
https://www.businesswire.com/news/home/20251112949094/en/Atara-Biotherapeutics-Announces-Third-Quarter-Financial-Results-and-Operational-Progress
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to dev...
atara biotherapeuticsthird quarterfinancial resultsannouncesoperational